Glutathione peroxidase-1 and homocysteine for cardiovascular risk prediction: results from the AtheroGene study. - Wikidata - wikimedia - TriplyDB

Glutathione peroxidase-1 and homocysteine for cardiovascular risk prediction: results from the AtheroGene study.

Glutathione peroxidase-1 and homocysteine for cardiovascular risk prediction: results from the AtheroGene study.

http://www.wikidata.org/entity/Q40422793

about

Redox Changes Induced by General Anesthesia in Critically Ill Patients with Multiple Traumas Redox regulation of mitochondrial function Genetics in arterial calcification: pieces of a puzzle and cogs in a wheel.Quo vadis: whither homocysteine research?Association of glutathione peroxidase-1 (GPx-1) rs1050450 Pro198Leu and Pro197Leu polymorphisms with cardiovascular risk: a meta-analysis of observational studies Irreversible inactivation of glutathione peroxidase 1 and reversible inactivation of peroxiredoxin II by H2O2 in red blood cells.Inhibition of cellular methyltransferases promotes endothelial cell activation by suppressing glutathione peroxidase 1 protein expression.Erythrocyte superoxide dismutase, glutathione peroxidase, and catalase activities and risk of coronary heart disease in generally healthy women: a prospective study.Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither?Case control feasibility study assessing the association between severity of coronary artery disease with Glutathione Peroxidase-1 (GPX-1) and GPX-1 polymorphism (Pro198Leu).Genetic association of glutathione peroxidase-1 with coronary artery calcification in type 2 diabetes: a case control study with multi-slice computed tomography.Nutrition in Pediatric Cardiomyopathy Study of oxidants and antioxidants in patients of acute myocardial infarction.Biomarkers of obesity and subsequent cardiovascular events Selenium supplementation improves antioxidant capacity in vitro and in vivo in patients with coronary artery disease The SElenium Therapy in Coronary Artery disease Patients (SETCAP) Study Baseline glutathione peroxidase activity affects prognosis after acute coronary syndromes.Low plasma selenium concentrations and mortality among older community-dwelling adults: the InCHIANTI Study.In Vitro Protective Effect of Phikud Navakot Extraction on Erythrocyte PTEN phosphorylation and nuclear export mediate free fatty acid-induced oxidative stress EURRECA-Estimating selenium requirements for deriving dietary reference values.Selenium in the prevention of atherosclerosis and its underlying mechanisms.Homocysteine and hydrogen sulfide in epigenetic, metabolic and microbiota related renovascular hypertension.Selenium supplementation does not improve vascular responsiveness in healthy North American men.Assessing the clinical utility of biomarkers in medicine.Activity of superoxide dismutase copper/zinc type and prognosis in a cohort of patients with coronary artery disease.Oxidative stress in ischemia and reperfusion: current concepts, novel ideas and future perspectives.Recombinant Human Cytoglobin Prevents Atherosclerosis by Regulating Lipid Metabolism and Oxidative Stress.High glucose-induced p53 phosphorylation contributes to impairment of endothelial antioxidant system.Neopterin as an Effect Modifier of the Cardiovascular Risk Predicted by Total Homocysteine: A Prospective 2-Cohort Study.Hydrogen sulfide mediates athero-protection against oxidative stress via S-sulfhydration.Association between Polymorphisms of Antioxidant Gene (MnSOD, CAT, and GPx1) and Risk of Coronary Artery Disease

P2860

Q26773598-7472238A-F2F6-49D1-AF0A-DF54167BDEEC Q28383361-C0119C85-D00A-4742-BF95-937E1E0FA17D Q33352008-ACFC6431-700B-4807-A426-9D25764192CE Q33457245-19BBA854-BD14-4059-BB07-1298B8260069 Q33826552-56A27E69-53A6-4D73-84B8-8FFD71D404C5 Q33874995-0B0C7959-2948-4AA6-AB04-2D2C20794A30 Q34075905-DE339BFC-66C1-471C-8AD7-FF109D158359 Q34395245-18450EFD-5B11-4A5E-8505-7AFC45B984FF Q35173610-26631AD1-AF44-438E-A9E9-171683B4E51E Q35175404-504FE33F-ED95-4C5F-B5BC-FB57D7AB1B68 Q36031134-DA59B672-353D-4339-886D-8C874B9F8FAA Q36092155-A60BA5C6-BEA5-4202-81A8-535681B4093F Q36296226-9DA94D3D-FC0B-44A2-AD77-FAD78820D90F Q36357728-2AA831A0-274B-40B5-9BD6-5FF4FB647A92 Q36381096-5606BED5-0A06-498A-8484-3489AF48528A Q36761023-532BDF0D-A0BC-48C1-B20B-F373DD6703B2 Q36932129-27829E0F-BF85-4F24-9238-B54C081F9705 Q37352357-AFFA0B88-EDD8-4A0C-ADCA-B0F7C0022F6B Q37492613-45B6D0EC-8F3A-429C-A69D-803752C44E12 Q37606460-5CBC5D7F-D541-4E35-AD4F-C338F18F5D40 Q38129415-DF2488D4-1209-4F4F-8EE3-48F24F5F996D Q38778791-2BADE72D-A12C-4C54-BBC2-A14A4D257FDB Q38948319-89F7849B-B781-4DC1-B97A-7A26EF0B25D5 Q40024661-625201F1-FE0F-4AEF-95C2-DE3EC54CA948 Q40169397-BB0C9ED1-6D1C-4A62-857B-BCF422F2851A Q41665458-C5D96C0B-D14C-4EA5-9F95-DECBDE735BE3 Q46283292-47DAF7AC-3FC0-4FFA-95A6-5427F531DDAD Q46299901-B9F789A3-0DD1-4F96-A49D-429EA5ACFCBE Q46341240-C53D2DF4-8F9B-46DC-95B9-631867BD04E3 Q47127539-1B00963D-46A2-4A56-816A-8E3C331816B8 Q55093308-0D7E6F8D-5150-4A4A-9B74-DAC9F6D1D6A2 Q58702128-EB8CF874-EA02-483F-BC56-CF552D629828

P2860

Glutathione peroxidase-1 and homocysteine for cardiovascular risk prediction: results from the AtheroGene study.

http://www.wikidata.org/entity/Q40422793

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Glutathione peroxidase-1 and h ...... lts from the AtheroGene study.

@en

type

label

Glutathione peroxidase-1 and h ...... lts from the AtheroGene study.

@en

prefLabel

Glutathione peroxidase-1 and h ...... lts from the AtheroGene study.

@en

P1433

Q40422793-319F370F-2625-4A95-BCA1-B58352942D54

P1476

Q40422793-136D7D4C-C759-42D1-80EF-D9FEA934B7A9

P2093

Q40422793-2174D19E-DDB4-416A-B55C-A94407D597FA

Q40422793-3B71C5E3-B363-4230-80A7-F93231F588CC

Q40422793-625585B8-86B3-441C-8897-4BBCEEE1D035

Q40422793-6400C9D9-B42B-4620-A827-B88ADC75B33F

Q40422793-7A920FF3-B65F-4F95-B637-8A9F4E12DED9

Q40422793-95FC4346-DB64-4812-BAA0-EFF4D9D134A5

Q40422793-9F47EC80-FAAF-4BBB-8FD1-0291F7BB38CD

Q40422793-E31773F2-ACEE-4C5E-AED0-AE8944ADB822

Q40422793-E3E5BB34-19A8-44F6-9D6F-4540455E8F50

Q40422793-FD3CAFB0-A97E-488D-AEFC-A70D5079E4AB

P304

Q40422793-7A2503BC-0BC9-4FE1-8CAE-704952BAA2CB

P31

Q40422793-4D872180-5ACE-42AC-983B-9FDE6FA8F503

P356

Q40422793-FD48837C-0528-4AB8-9E3E-35341CAE364B

P407

Q40422793-6B6D2041-6133-4BD7-93E1-DC98C09AC0B7

P433

Q40422793-8F296F83-D9DD-4611-8C81-9BDB697A709D

P478

Q40422793-90DAC16D-3643-428B-8B41-93E5D560023B

P577

Q40422793-216C517F-A69D-4F58-B738-D84A04ECD74F

P5875

Q40422793-BE2B6BB3-40C3-46D5-BF7A-19593334C149

P698

Q40422793-A6FA957A-28D4-4DD8-8F53-7BB4670776D8

P356

J.JACC.2005.02.053

P1433

Journal of the American College of Cardiology

P1476

Glutathione peroxidase-1 and h ...... lts from the AtheroGene study.

@en

P2093

Christine Espinola-Klein

http://www.w3.org/2001/XMLSchema#string

Christoph Bickel

http://www.w3.org/2001/XMLSchema#string

Edith Lubos

http://www.w3.org/2001/XMLSchema#string

François Cambien

http://www.w3.org/2001/XMLSchema#string

Hans J Rupprecht

http://www.w3.org/2001/XMLSchema#string

Karl J Lackner

http://www.w3.org/2001/XMLSchema#string

Laurence Tiret

http://www.w3.org/2001/XMLSchema#string

Michael Torzewski

http://www.w3.org/2001/XMLSchema#string

Renate Schnabel

http://www.w3.org/2001/XMLSchema#string

Stefan Blankenberg

http://www.w3.org/2001/XMLSchema#string

P304

1631-1637

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACC.2005.02.053

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P577

2005-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7848556

http://www.w3.org/2001/XMLSchema#string

P698

15893179

http://www.w3.org/2001/XMLSchema#string